Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Laduron

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
European Journal of Pharmacology|February 7, 1991
Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the ratJ M Stutzmann, G A Böhme, G Gandolfo, et al.
European Journal of Pharmacology|March 15, 1993
Interaction of the substance P receptor antagonist RP 67580 with the rat brain NK1 receptor expressed in transfected CHO cellsE Hermans, A P Jeanjean, V Fardin, et al.
Journal of Medicinal Chemistry|July 30, 1999
Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolinesP Jimonet, F Audiau, M Barreau, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
European Journal of Pharmacology|February 7, 1991
Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the ratJ M Stutzmann, G A Böhme, G Gandolfo, et al.
European Journal of Pharmacology|March 15, 1993
Interaction of the substance P receptor antagonist RP 67580 with the rat brain NK1 receptor expressed in transfected CHO cellsE Hermans, A P Jeanjean, V Fardin, et al.
Journal of Medicinal Chemistry|July 30, 1999
Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolinesP Jimonet, F Audiau, M Barreau, et al.
Pageof 14